A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris

Trial Profile

A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Dapsone (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 08 Mar 2016 Pooled results (n=4340) assessing the effects of age, gender and race of this and other trial (see profile: 238538) presented at the 74th Annual Meeting of the American Academy of Dermatology
    • 08 Mar 2016 Pooled results (n=4340) assessing the efficacy and safety of this and other trial (see profile: 238538) presented at the 74th Annual Meeting of the American Academy of Dermatology
    • 08 Mar 2016 Primary endpoint (Change from Baseline in Noninflammatory Facial Lesion Counts) has been met, as per the results presented at the 74th Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top